Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-01-06
1994-11-29
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
554218, A61K 3120, C07C 5900
Patent
active
053691261
ABSTRACT:
A compound of the formula ##STR1## its pharmaceutically acceptable salts, and its pharmaceutically acceptable hydrolyzable esters for reducing sebum secretion and combatting acne as well as oral and topical compositions for use thereof.
REFERENCES:
patent: 4648996 (1987-03-01), Alig et al.
Doran T., et al, Characterization of human sebaceous cell in vitro. J. Invest. Dermatol. 96: 341-348 (1991).
Farrell L., et al, The treatment of severe cystic acne with 13-cisretinoic acid. J. Amer. Acad. Dermatol. 3: 602-611 (1980).
Hammerstein J., et al, Use of cyproteron acetate in the treatment of acne, hirsutism and virilism. J. Steroid Biochem. 6: 827-836 (1975).
Karasek M., Isolation and characterization of cells from the human sebaceous gland. In Vitro 22: No. 3, Part II, p. 22a, abstract No. 46 (1986).
Knutson D., Ultrastructural observations in acne vulgaris. The normal sebaceous follicles and acne lesions. J. Invest. Dermatol. 62: 288-307 (1974).
Landthaler M., et al, Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands. Arch. Dermatol. Res. 269: 297-309 (1980).
Lavker M., et al, Lamellar inlcusions in follicular horny cell: a new aspect of abnormal keratinization. J. Ultrastruc. Molec. Struct. Res: 69: 362-370 (1979).
Lavker M., et al, The relationship between bacteria and the abnormal fillcular keratinization in acne vulgaris, J. Invest. Dermatol. 77: 325-330 (1981).
Lyons F., et al, comparison of 13-cis-retinoic acid and cyproterone acetate on the clinical response, sebum secretion, dermal and epidermal lipogensis in acne. Br. J. Dermatol, 106: 728-734 (1982).
Mezick J., et al, Topical and systemic effects of retinoids on horn-filled urticulus size in the rhino mouse. A model to quantify "antikeratinizing" effects of retinoids. J. Invest. Dermatol. 83: 110-113 (1984).
Plewig G., et al, Hamster ear model for sebaceous glands. J. Invest. Dermatol. 68 171-176 (1977).
Plewig G., et al, Effects of two retinoids in animal experiements and after clinical application in acne patients: 13-cis-retinoic acid Ro 4-3780 and aromatic retinoid Ro 10"9359. In "Retinoids", CE Orfanos et al., ed., Springer-Verlag, pp. 219-235 (1981).
Rheinwald J., et al, Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6: 331-334 (1975).
Shapiro S., et al, Evaluation of Potential Therapeutic Entities for the Treatment of Acne. In Reichert U and Shoot B (eds): "Pharmacology of Retinoids in the Skin." Pharmacol. Skin, Basel, Karger, vol. 3, pp. 104-112 (1989).
Vane F., et al, Human biliary metabolites of isotretinoin: Identification, quantitation, synthesis, and biological activity. Xenobiotica 20: 193-207 (1990).
Weissman A., et al, Antiandrogenic effects of topically applied spironolactone on the hamster flank organ. Arch. Dermatol. 121: 57-62 (1985).
Wolff H., et al, Ulstrastructure of human sebaceous sollicles and comedones following treatment with vitamin A. Acta. Derm. Vener. Stockh., Suppl. 74, pp. 99-110 (1975).
Doran Thomas I.
Rosenberger Michael
Shapiro Stanley S.
Conrad, III Joseph M.
Dees Jos,e G.
Epstein William H.
Gould George M.
Hoffmann-La Roche Inc.
LandOfFree
Nonatetraenoic acid derivative for use in treating acne does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonatetraenoic acid derivative for use in treating acne, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonatetraenoic acid derivative for use in treating acne will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-74479